Tumor necrosis factor-α alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function

Stem Cells and Development

Volumn 18, Issue 10, 2009, Pages 1473-1484

  Zhu, Heng ^a   Jiang, Xiao Xia ^a   Guo, Zi Kuan ^b   Li, Hong ^a   Su, Yong Feng ^a   Yao, Hui Yu ^a   Wang, Xiao Yan ^a   Li, Xiu Sen ^a   Wu, Ying ^a   Liu, Yuan Lin ^a   Zhang, Yi ^a   Mao, Ning ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL REGENERATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; MONOCYTE; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID;

ANIMALS; ANTIGENS, CD11B; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; MULTIPOTENT STEM CELLS; OSTEOCLASTS; OSTEOPROTEGERIN; RNA, MESSENGER; SOLUBILITY; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 72849127799     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0021     Document Type: Article

References (49)

1. Friedenstein AJ, JF Gorskaja and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.
2. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
3. Dennis JE, A Merriam, A Awadallah, JU Yoo, B Johnstone and AI Caplan. (1999). A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 14:700-709.
4. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
5. da Silva Meirelles L, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J Cell Sci 119:2204-2213.
6. Verfaillie CM. (1998). Adhesion receptors as regulators of the hematopoietic process. Blood 92:2609-2612.
7. Blazsek I, J Chagraoui and B Peault. (2000). Ontogenic emergence of the hematon, a morphogenetic stromal unit that supports multipotential hematopoietic progenitors in mouse bone marrow. Blood 96:3763-3771.
8. Sacchetti B, A Funari, S Michienzi, S Di Cesare, S Piersanti, I Saggio, E Tagliafi co, S Ferrari, PG Robey, M Riminucci and P Bianco. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336.
9. Majumdar MK, M Keane-Moore, D Buyaner, WB Hardy, MA Moorman, KR McIntosh and JD Mosca. (2003). Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10:228-241.
10. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecifi c mitogenic stimuli. Blood 99:3838-3843.
11. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822.
12. Corcione A, F Benvenuto, E Ferretti, D Giunti, V Cappiello, F Cazzanti, M Risso, F Gualandi, GL Mancardi, V Pistoia and A Uccelli. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372.
13. Spaggiari GM, A Capobianco, S Becchetti, MC Mingari and L Moretta. (2006). Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484-1490.
14. Spaggiari GM, A Capobianco, H Abdelrazik, F Becchetti, MC Mingari and L Moretta. (2008). Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327-1333.
15. Jiang XX, Y Zhang, B Liu, SX Zhang, Y Wu, XD Yu and N Mao. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120-4126.
16. Pereira RF, MD O'Hara, AV Laptev, KW Halford, MD Pollard, R Class, D Simon, K Livezey and DJ Prockop. (1998). Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:1142-1147.
17. Lee RH, MJ Seo, RL Reger, JL Spees, AA Pulin, SD Olson and DJ Prockop. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 103:17438-17443.
18. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441.
19. Li H, Z Guo, X Jiang, H Zhu, X Li and N Mao. (2008). Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells 26:2531-2541.
20. Zappia E, S Casazza, E Pedemonte, F Benvenuto, I Bonanni, E Gerdoni, D Giunti, A Ceravolo, F Cazzanti, F Frassoni, G Mancardi and A Uccelli. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755-1761.
21. Djouad F, V Fritz, F Apparailly, P Louis-Plence, C Bony, J Sany, C Jorgensen and D Noel. (2005). Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis Arthritis Rheum 52(5):1595-1603
22. Augello A, R Tasso, SM Negrini, R Cancedda and G Pennesi. (2007). Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56:1175-1186.
23. Teitlelbaum SL. (2000). Bone resorption by osteoclasts. Science 289:1504-1508.
24. Yasuda H, N Shima, N Nakagawa, K Yamaguchi, M Kinosaki, S Mochizuki, A Tomoyasu, K Yano, M Goto, A Murakami, E Tsuda, T Morinaga, K Higashio, N Udagawa, N Takahashi and T Suda. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95(7):3597-3602.
25. Lacey DL, E Timms, HL Tan, MJ Kelley, CR Dunstan, T Burgess, R Elliott, A Colombero, G Elliott, S Scully, H Hsu, J Sullivan, N Hawkins, E Davy, C Capparelli, A Eli, YX Qian, S Kaufman, I Sarosi, V Shalhoub, G Senaldi, J Guo, J Delaney and WJ Boyle. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
26. Pfeilschifter J, C Chenu, A Bird, GR Mundy and GD Roodman. (1989). Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast like cells in vitro. J Bone Miner Res 4(1):113-118.
27. Kobayashi K, N Takahashi, E Jimi, N Udagawa, M Takami, S Kotake, N Nakagawa, M Kinosaki, K Yamaguchi, N Shima, H Yasuda, T Morinaga, K Higashio, TJ Martin and T Suda. (2000). Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286.
28. Simonet WS, DL Lacey, CR Dunstan, M Kelley, MS Chang, R Luthy, HQ Nguyen, S Wooden, L Bennett, T Boone, G Shimamoto, M DeRose, R Elliott, A Colombero, HL Tan, G Trail, J Sullivan, E Davy, N Bucay, L Renshaw-Gegg, TM Hughes, D Hill, W Pattison, P Campbell, S Sander, G Van, J Tarpley, P Derby, R Lee and WJ Boyle. (1997). Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89(2):309-319.
29. Kollet O, A Dar, S Shivtiel, A Kalinkovich, K Lapid, Y Sztainberg, M Tesio, RM Samstein, P Goichberg, A Spiegel, A Elson and T Lapidot. (2006). Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12(6):657-664.
30. Purton LE and DT Scadden. (2006). Osteoclasts eat stem cells out of house and home. Nat Med 12(6):610-611.
31. Koga T, M Inui, K Inoue, S Kim, A Suematsu, E Kobayashi, T Iwata, H Ohnishi, T Matozaki, T Kodama, T Taniguchi, H Takayanagi and T Takai. (2004). Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428(6984):758-763.
32. Miyamoto T, O Ohneda, F Arai, K Iwamoto, S Okada, K Takagi, DM Anderson and T Suda. (2001). Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98(8):2544-2554.
33. Guo Z, H Li, X Li, X Yu, H Wang, P Tang and N Mao. (2006). In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells 24:992-1000.
34. Rivollier A, M Mazzorana, J Tebib, M Piperno, T Aitsiselmi, C Rabourdin-Combe, P Jurdic and C Servet-Delprat. (2004). Immature dendritic cell transdifferentiation into osteoclasts: A novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104(13):4029-4037.
35. Boyce BF and L Xing. (2008). Functions of RANKL/RANK/ OPG in bone modeling and remodeling. Arch Biochem Biophys 473(2):139-146.
36. Kwan Tat S, M Padrines, S Theoleyre, D Heymann and Y Fortun. (2004). IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15(1):49-60.
37. Boyce BF, P Li, Z Yao, Q Zhang, IR Badell, EM Schwarz, RJ O'Keefe and L Xing. (2005). TNF-alpha and pathologic bone resorption. Keio J Med 54(3):127-131.
38. Mbalaviele G, N Jaiswal, A Meng, L Cheng, C Van Den Bos and M Thiede. (1999). Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology 140(8):3736-3743.
39. Tanaka S, N Takahashi, N Udagawa, T Tamura, T Akatsu, ER Stanley, T Kurokawa and T Suda. (1993). Macrophage colonystimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91: 257-263. (Pubitemid 23037280)
40. Ishimi Y, C Miyaura, CH Jin, T Akatsu, E Abe, Y Nakamura, A Yamaguchi, S Yoshiki, T Matsuda and T Hirano. (1990). IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145(10):3297-3303.
41. Mbalaviele G, R Nishimura, A Myoi, M Niewolna, SV Reddy, D Chen, J Feng, D Roodman, GR Mundy and T Yoneda. (1998). Cadherin-6 mediates the heterotypic interactions between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation. J Cell Biol 141(6): 1467-1476.
42. Azuma Y, K Kaji, R Katogi, S Takeshita and A Kudo. (2000). Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275(7):4858-4864.
43. Lam J, S Takeshita, JE Barker, O Kanagawa, FP Ross and SL Teitelbaum. (2000). TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106(12):1481-1488.
44. Takai H, M Kanematsu, K Yano, E Tsuda, K Higashio, K Ikeda, K Watanabe and Y Yamada. (1998). Transforming growth factorbeta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273(42):27091-27096.
45. Stein NC, C Kreutzmann, SP Zimmermann, U Niebergall, L Hellmeyer, C Goettsch, M Schoppet and LC Hofbauer. (2008). Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway. J Bone Miner Res 23(5):750-758.
46. Pantouli E, MM Boehm and S Koka. (2005). Infl ammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells. Biochem Biophys Res Commun 329(1):224-229.
47. Lambert C, C Oury, E Dejardin, A Chariot, J Piette, M Malaise, MP Merville and N Franchimont. (2007). Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells. J Bone Miner Res 22(9):1350-1361.
48. Kondo T, R Kitazawa, A Yamaguchi and S Kitazawa. (2008). Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J Cell Biochem 103(1):335-345.
49. McInnes IB and FY Liew. (2005). Cytokine network towards new therapies for rheumatoid arthritis. Nature Clin Pract Rheumatol 1:31-39.